Endothelial Dysfunction The First Step Toward Coronary Arteriosclerosis

1. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-376.

2. Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB 1989; J3: 2007-2017.

3. Luscher TF, Vanhoutte PM. The Endothelium: Modulator of Cardiovascular Function. Boca Raton: CRC Press, Inc; 1990; 1-228.

4. Furchgott RF. Studies on relaxation of rabbit aorta by sodium nitrite: The basis for the proposal that acid-activatable inhibitory factor from bovine retractor penis is inorganic nitrite and the endothelium-derived relaxing factor is nitric oxide. <i>In:</i> Vanhoutte PM, editor. Vasodilatation: Vascular Smooth Muscle, Peptides, Autonomic Nerves and Endothelium. New York: Raven Press; 1988; 401-414.

5. Ignarro LJ, Byrns RE, Wood KS. Biochemical and pharmacological properties of endothelium-derived relaxing factor and its similarity to nitric oxide radical. <i>In:</i> Vanhoutte, PM, editor. Vasodilatation: Vascular Smooth Muscle, Peptides, Autonomic Nerves and Endothelium. New York: Raven Press; 1988; 427-436.

10.1111/j.1749-6632.1997.tb51989.x

7. Busse R, Edwards G, Feletou M, Fleming I, Vanhoutte PM. EDHF: Bringing the concepts together. Trends in Pharmacol Sci 2002; 23: 374-380.

8. Feletou M, Vanhoutte PM. EDHF: The Complete Story. Boca Raton: CRC Taylor and Francis; 2006; 1-298.

9. Feletou M, Vanhoutte PM. Endothelium-dependent hyperpolarizations: Past beliefs and present facts. Ann Med 2007; 39: 495-516.

10. Vanhoutte PM. Other endothelium-derived vasoactive factors. Circulation 1993; 87: V-9-V-17.

10.1038/sj.bjp.0706042

12. Vanhoutte PM. The endothelium-modulator of vascular smooth-muscle tone. N Engl J Med 1988; 319: 512-513.

10.1097/00004872-199609002-00016

10.1016/S0195-668X(97)90005-1

10.1016/S1520-765X(02)90068-4

16. Vanhoutte PM. Endothelial control of vasomotor function: From health to coronary disease. Circ J 2003; 67: 572-575.

17. Feletou M, Vanhoutte PM. Endothelial dysfunction: A multifaceted disorder (The Wiggers Award Lecture). Am J Physiol Heart Circ Physiol 2006; 291: H985-H1002.

18. Vanhoutte PM, Shimokawa H, Tang EHC, Feletou M. Endothelial dysfunction: Setting the stage for coronary disease. Acta Physiol Scand 2008 (in press).

19. Vanhoutte PM, Tang EHC. Endothelium-dependent contractions: When a good guy turns bad. J Physiol 2008; 586: 5295-5304.

20. Vanhoutte PM, Shimokawa H. Endothelium-derived relaxing factor and coronary vasospasm. Circulation 1989; 80: 1-9.

10.1016/0968-0004(89)90181-3

22. Li H, Wallerath T, Forstermann U. Physiological mechanisms regulating the expression of endothelial-type NO synthase. Nitric Oxide 2002; 7: 132-147.

23. Li H, Wallerath T, Munzel T, Forstermann U. Regulation of endothelial-type NO synthase expression in pathophysiology and in response to drugs. Nitric Oxide 2002; 7: 149-164.

24. Feron O, Balligand J. Caveolins and the regulation of endothelial nitric oxide synthase in the heart. Cardiovasc Res 2006; 69: 788-797.

25. O'Rourke ST, Vanhoutte PM, Miller VM. Biology of blood vessels. <i>In:</i> Creager MA, Dzau V, Loscalso J, editors. Vascular Medicine, A Companion to Braunwald's Heart Disease. Philadelphia, PA: Elsevier; 2006; 71-100.

26. Ross R. Atherosclerosis. An inflammatory disease. N Engl J Med 1999; 340: 115-126.

10.1007/s00418-004-0675-z

28. Davies PF. Flow-mediated endothelial mechanotransduction. Physiol Rev 1995; 75: 519-560.

29. Busse R, Fleming I. Regulation of endothelium-derived vasoactive autacoid production by hemodynamic forces. Trends in Pharmacol Sci 2003; 24: 24-29.

30. Miller VM, Duckles SP. Vascular actions of estrogens: Functional implications. Pharmacol Rev 2008; 60: 210-241.

10.1016/S0008-6363(99)00169-8

10.1172/JCI10506

10.1016/j.yjmcc.2005.07.007

10.1253/circj.71.1173

10.1253/circj.71.698

10.1038/sj.bjp.0703393

37. Vanhoutte PM. Hypercholesterolaemia, atherosclerosis and release of endothelium derived relaxing factor by aggregation platelets. Eur Heart J 1991; 12: 25-32.

10.1152/physrev.00047.2003

39. Brandes RP. Roads to dysfunction: Argininase II contributes to oxidized low-density lipoprotein-induced attenuation of endothelial NO production. Circ Res 2006; 99: 918-920.

40. Aikawa M, Libby P. The vulnerable atherosclerotic plaque pathogenesis and therapeutic approach. Cardiovasc Path 2004; 13: 125-138.

41. Bos CL, Richel DJ, Ritsema T, Peppelenbosch MP, Versteeg HH. Prostanoids and prostanoid receptors in signal transduction. Int J Biochem Cell Biol 2004; 26: 1187-1205.

42. Feletou M, Tang EHC, Vanhoutte PM. Nitric oxide, the gatekeeper of endothelial vasomotor control. Front Biosci 2008; 13: 4198-4217.

10.1006/jmcc.1998.0841